CVS Group (LON:CVSG) Earns Buy Rating from Berenberg Bank

CVS Group (LON:CVSG)‘s stock had its “buy” rating restated by equities research analysts at Berenberg Bank in a research report issued to clients and investors on Thursday, Marketbeat Ratings reports. They presently have a GBX 2,000 price target on the stock. Berenberg Bank’s target price would indicate a potential upside of 65.56% from the company’s current price.

A number of other analysts have also recently issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,700 price objective on shares of CVS Group in a research report on Monday, July 27th. Jefferies Financial Group raised their price target on CVS Group from GBX 1,350 to GBX 1,400 and gave the stock a “hold” rating in a research note on Friday, July 31st. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.

CVS Group Stock Down 1.1%

CVSG stock opened at GBX 1,208 on Thursday. CVS Group has a 12-month low of GBX 1,062 and a 12-month high of GBX 1,648. The company has a quick ratio of 0.90, a current ratio of 1.18 and a debt-to-equity ratio of 110.41. The company has a market cap of £821.08 million, a price-to-earnings ratio of 17.53, a PEG ratio of 1.77 and a beta of 1.07. The company has a 50 day moving average of GBX 1,287.09 and a two-hundred day moving average of GBX 1,229.43.

CVS Group (LON:CVSG) last posted its quarterly earnings results on Thursday, September 24th. The company reported GBX 85.60 EPS for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. On average, equities analysts anticipate that CVS Group will post 93.9393939 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider David Wilton bought 1,500 shares of the business’s stock in a transaction on Tuesday, August 4th. The shares were bought at an average cost of GBX 1,276 per share, for a total transaction of £19,140. Also, insider Joanne Shaw bought 1,592 shares of the business’s stock in a transaction on Monday, August 10th. The shares were bought at an average price of GBX 1,287 per share, for a total transaction of £20,489.04. Insiders have acquired 3,860 shares of company stock valued at $4,956,696 over the last three months. 1.48% of the stock is currently owned by insiders.

Key Stories Impacting CVS Group

Here are the key news stories impacting CVS Group this week:

• Positive Sentiment: Dividend supported by shareholder returns: CVS Group recommended a final dividend for the year ended June 30, 2026, payable on December 4, providing an income component for investors. CVS Group recommends final dividend
• Positive Sentiment: Insider purchase offers a modest confidence signal: Non-executive director Laura Hagan bought 4,128 CVS Group shares. The transaction may reassure investors about management’s view of the company’s valuation, although its financial impact is limited. CVS Group director share purchase
• Positive Sentiment: Berenberg maintained a Buy rating and a GBX 2,000 price target, implying substantial upside from the stock’s recent trading level. Berenberg rating update
• Neutral Sentiment: Full-year results were released: CVS Group reported GBX 85.60 in earnings per share, alongside a 2.31% net margin and 5.35% return on equity. The figures provide a fresh performance update, but the relatively low profitability metrics may limit enthusiasm without further detail on growth and costs. CVS Group full-year earnings results
• Negative Sentiment: Analyst caution remains the main pressure: Shore Capital reaffirmed its Hold rating and GBX 1,400 target, while Jefferies also maintained Hold with the same target. The repeated neutral recommendations suggest limited near-term conviction despite the higher Berenberg target. Shore Capital Hold rating

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.